Sex Hormone Estrone Sulfate Serendipitously Downregulates Intercellular Tunneling Nanotube Conduits, EMT, and Migration in Breast and Pancreatic Cancer Cells
- 1Department of Biomedical & Molecular Sciences, Queen’s University, Kingston, ON K7L 3N6, Canada
Abstract
Aim: Estrone (E1) is of particular interest as most breast cancers are diagnosed after menopause, the period in which E1 becomes the dominant estrogen. Triple-negative breast cancer (TNBC) is a highly invasive cancer that lacks hormone receptors for estrogen (ER), progesterone (PR), and HER2 (human epidermal growth factor receptor-2). TNBC management remains clinically challenging despite recent advances in targeted and immunotherapeutic approaches. This study investigated the effects of the estrogen hormone estrone sulfate (E1S) on cancer cells. Here, E1S engages in non-classical biased G protein-coupled estrogen receptor (GPER) signaling in TNBC MDA-MB-231 cells, estrogen receptor-positive MCF-7 breast cancer cells, and pancreatic PANC-1 cancer cells, which express estrogen, progesterone, and androgen receptors. Methods: We performed sialidase and colocalization assays in breast MDA-MB-231 and MCF-7 cells and pancreatic PANC-1 cancer cells. An epithelial-to-mesenchymal (EMT) transition, a tunneling nanotube assay, and a scratch wound assay were conducted to elucidate the cellular behaviors of E1S. We used a RawBlue reporter macrophage cell line to measure NFκB activity using the secreted embryonic alkaline phosphatase (SEAP) assay, and we measured cellular viability and metabolic activity using the AlamarBlue assay. Results: E1S induced NMBR/MMP9/Neu1 signaling in MDA-MB-231, MCF-7, PANC-1 and RawBlue cells. E1S increased E-cadherin expression, reduced N-cadherin and vimentin expression, decreased tunneling nanotube density, and reduced scratch wound migration. E1S increased SEAP activity, suggestive of increased nuclear factor-κB (NF-κB) and activator protein-1 (AP-1)-mediated transcription. E1S treatment did not affect cell viability and metabolic activity in triple-negative MDA-MB-231 breast cells using the AlamarBlue assay in a dose-dependent manner. Conclusions: E1S binding to GPER potentiates a biased heterodimerization with the GPCR neuromedin B receptor (NMBR) to activate matrix metalloproteinase 9 (MMP9) and neuraminidase 1 (Neu1), a signaling paradigm with previously established receptor tyrosine kinase (RTK) and Toll-like (TLR) receptors. Biased, temporal GPER signaling has significant implications for breast and pancreatic cancer cellular behavior, which may be leveraged to inform therapeutic strategies for aggressive forms of breast and pancreatic cancers. This research study is mechanistic in nature and may have potential translational implications.
Related
- An interferon-like off-switch in invertebrates: Vago4 downregulates Domeless to restrain JAK/STAT signaling
- Prenatal Alcohol Exposure Downregulates Focal Adhesion Molecules Tensin 1 and Tensin 2 Contributing to Cerebrovascular Dysfunction
- Encephalitic alphavirus infection reduces neurite outgrowth and downregulates Rho GTPase pathways in human iPSC-derived neurospheres
- MiR-22-3p shapes glioblastoma radiation resistance and downregulates the DNA demethylase tumor suppressor TET1
- Cardiomyocyte Identity Crisis Without Regenerative Re-entry: A Multi-Scale Atlas of Incomplete Dedifferentiation and Intercellular Communication Rewiring in the Infarcted Human Heart
BibTeX
@article{wahab2026hormone,
title = {{Sex Hormone Estrone Sulfate Serendipitously Downregulates Intercellular Tunneling Nanotube Conduits, EMT, and Migration in Breast and Pancreatic Cancer Cells}},
author = {Izzah Wahab and Yunfan Li and Myron R. Szewczuk},
journal = {Cancers},
year = {2026},
month = oct,
doi = {10.3390/cancers18203354},
url = {https://www.mdpi.com/2072-6694/18/20/3354},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Sex Hormone Estrone Sulfate Serendipitously Downregulates Intercellular Tunneling Nanotube Conduits, EMT, and Migration in Breast and Pancreatic Cancer Cells
AU - Izzah Wahab
AU - Yunfan Li
AU - Myron R. Szewczuk
PY - 2026
DA - 2026/10/16
JO - Cancers
DO - 10.3390/cancers18203354
UR - https://www.mdpi.com/2072-6694/18/20/3354
AB - Aim: Estrone (E1) is of particular interest as most breast cancers are diagnosed after menopause, the period in which E1 becomes the dominant estrogen. Triple-negative breast cancer (TNBC) is a highly invasive cancer that lacks hormone receptors for estrogen (ER), progesterone (PR), and HER2 (human epidermal growth factor receptor-2). TNBC management remains clinically challenging despite recent advances in targeted and immunotherapeutic approaches. This study investigated the effects of the estrogen hormone estrone sulfate (E1S) on cancer cells. Here, E1S engages in non-classical biased G protein-coupled estrogen receptor (GPER) signaling in TNBC MDA-MB-231 cells, estrogen receptor-positive MCF-7 breast cancer cells, and pancreatic PANC-1 cancer cells, which express estrogen, progesterone, and androgen receptors. Methods: We performed sialidase and colocalization assays in breast MDA-MB-231 and MCF-7 cells and pancreatic PANC-1 cancer cells. An epithelial-to-mesenchymal (EMT) transition, a tunneling nanotube assay, and a scratch wound assay were conducted to elucidate the cellular behaviors of E1S. We used a RawBlue reporter macrophage cell line to measure NFκB activity using the secreted embryonic alkaline phosphatase (SEAP) assay, and we measured cellular viability and metabolic activity using the AlamarBlue assay. Results: E1S induced NMBR/MMP9/Neu1 signaling in MDA-MB-231, MCF-7, PANC-1 and RawBlue cells. E1S increased E-cadherin expression, reduced N-cadherin and vimentin expression, decreased tunneling nanotube density, and reduced scratch wound migration. E1S increased SEAP activity, suggestive of increased nuclear factor-κB (NF-κB) and activator protein-1 (AP-1)-mediated transcription. E1S treatment did not affect cell viability and metabolic activity in triple-negative MDA-MB-231 breast cells using the AlamarBlue assay in a dose-dependent manner. Conclusions: E1S binding to GPER potentiates a biased heterodimerization with the GPCR neuromedin B receptor (NMBR) to activate matrix metalloproteinase 9 (MMP9) and neuraminidase 1 (Neu1), a signaling paradigm with previously established receptor tyrosine kinase (RTK) and Toll-like (TLR) receptors. Biased, temporal GPER signaling has significant implications for breast and pancreatic cancer cellular behavior, which may be leveraged to inform therapeutic strategies for aggressive forms of breast and pancreatic cancers. This research study is mechanistic in nature and may have potential translational implications.
SN - 2072-6694
ER -